Eileen Hu
Impact in
-
- Multiple Myeloma Research and Treatments
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Genetics 5
- Chronic Lymphocytic Leukemia Research 5
-
- Advanced biosensing and bioanalysis techniques 1
- Protein Degradation and Inhibitors 1
- Single-cell and spatial transcriptomics 1
- Co-authors
- Christopher J. Ott (1 shared paper)Michael S. Lawrence (1 shared paper)Johannes Kreuzer (1 shared paper)Raghu Vannam (1 shared paper)Robert Morris (1 shared paper)Wilhelm Haas (1 shared paper)Xcanda Ixchel Herrera Lopez (1 shared paper)Sebastian Palacios (1 shared paper)
- Journals
- Blood (2 papers)Journal of Translational Medicine (1 paper)Frontiers in Oncology (1 paper)Nature Communications (1 paper)Cell chemical biology (1 paper)
- Partner nations
- United States
In The Last Decade
Eileen Hu
11 papers receiving 208 citations
Peers
Comparison fields: 5 of 65
- Hematology 36
- Genetics 28
- Molecular Biology 141
- Oncology 50
- Immunology 26
Countries citing papers authored by Eileen Hu
This map shows the geographic impact of Eileen Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen Hu more than expected).
Fields of papers citing papers by Eileen Hu
This network shows the impact of papers produced by Eileen Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen Hu. The network helps show where Eileen Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Eileen Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 102 | |
| 2 | 2018 | 37 | |
| 3 | 2015 | 24 | |
| 4 | 2022 | 23 | |
| 5 | 2019 | 10 | |
| 6 | 2020 | 7 | |
| 7 | 2020 | 3 | |
| 8 | 2019 | 3 | |
| 9 | 2020 | 2 | |
| 10 | 2017 | 1 | |
| 11 | 2019 | 1 |
About Eileen Hu
Eileen Hu is a scholar working on Genetics, Molecular Biology, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 11 papers that have together received 213 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), CAR-T cell therapy research (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Advanced biosensing and bioanalysis techniques (1 paper), Protein Degradation and Inhibitors (1 paper) and Single-cell and spatial transcriptomics (1 paper). The work is most often cited by research in Hematology (36 citations), Genetics (28 citations), Molecular Biology (141 citations), Oncology (50 citations) and Immunology (26 citations). Eileen Hu has collaborated with scholars based in United States. Frequent co-authors include Christopher J. Ott, Michael S. Lawrence, Johannes Kreuzer, Raghu Vannam, Robert Morris, Wilhelm Haas, Xcanda Ixchel Herrera Lopez, Sebastian Palacios, Noreen Wauford and Breanna DiAndreth. Their work appears in journals such as Blood, Journal of Translational Medicine, Frontiers in Oncology, Nature Communications and Cell chemical biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.